Gene	Gene synonym	Ensembl	Gene description	Uniprot	Chromosome	Position	Protein class	Biological process	Molecular function	Disease involvement	Evidence	HPA evidence	UniProt evidence	NeXtProt evidence	MS evidence	RNA tissue specificity	RNA tissue distribution	RNA tissue specificity score	RNA tissue specific NX	RNA single cell type specificity	RNA single cell type distribution	RNA single cell type specificity score	RNA single cell type specific NX	RNA cancer specificity	RNA cancer distribution	RNA cancer specificity score	RNA cancer specific FPKM	RNA brain regional specificity	RNA brain regional distribution	RNA brain regional specificity score	RNA brain regional specific NX	RNA blood cell specificity	RNA blood cell distribution	RNA blood cell specificity score	RNA blood cell specific NX	RNA blood lineage specificity	RNA blood lineage distribution	RNA blood lineage specificity score	RNA blood lineage specific NX	RNA cell line specificity	RNA cell line distribution	RNA cell line specificity score	RNA cell line specific NX	RNA mouse brain regional specificity	RNA mouse brain regional distribution	RNA mouse brain regional specificity score	RNA mouse brain regional specific pTPM	RNA pig brain regional specificity	RNA pig brain regional distribution	RNA pig brain regional specificity score	RNA pig brain regional specific pTPM	Antibody	Reliability (IH)	Reliability (Mouse Brain)	Reliability (IF)	Subcellular location	Secretome location	CCD Protein	CCD Transcript	Blood concentration - Conc. blood IM [pg/L]	Blood concentration - Conc. blood MS [pg/L]	Subcellular main location	Subcellular additional location	Antibody RRID	Pathology prognostics - Breast cancer	Pathology prognostics - Cervical cancer	Pathology prognostics - Colorectal cancer	Pathology prognostics - Endometrial cancer	Pathology prognostics - Glioma	Pathology prognostics - Head and neck cancer	Pathology prognostics - Liver cancer	Pathology prognostics - Lung cancer	Pathology prognostics - Melanoma	Pathology prognostics - Ovarian cancer	Pathology prognostics - Pancreatic cancer	Pathology prognostics - Prostate cancer	Pathology prognostics - Renal cancer	Pathology prognostics - Stomach cancer	Pathology prognostics - Testis cancer	Pathology prognostics - Thyroid cancer	Pathology prognostics - Urothelial cancer	Tissue RNA - adipose tissue [NX]	Tissue RNA - adrenal gland [NX]	Tissue RNA - amygdala [NX]	Tissue RNA - appendix [NX]	Tissue RNA - basal ganglia [NX]	Tissue RNA - bone marrow [NX]	Tissue RNA - breast [NX]	Tissue RNA - cerebellum [NX]	Tissue RNA - cerebral cortex [NX]	Tissue RNA - cervix, uterine [NX]	Tissue RNA - colon [NX]	Tissue RNA - corpus callosum [NX]	Tissue RNA - ductus deferens [NX]	Tissue RNA - duodenum [NX]	Tissue RNA - endometrium 1 [NX]	Tissue RNA - epididymis [NX]	Tissue RNA - esophagus [NX]	Tissue RNA - fallopian tube [NX]	Tissue RNA - gallbladder [NX]	Tissue RNA - heart muscle [NX]	Tissue RNA - hippocampal formation [NX]	Tissue RNA - hypothalamus [NX]	Tissue RNA - kidney [NX]	Tissue RNA - liver [NX]	Tissue RNA - lung [NX]	Tissue RNA - lymph node [NX]	Tissue RNA - midbrain [NX]	Tissue RNA - olfactory region [NX]	Tissue RNA - ovary [NX]	Tissue RNA - pancreas [NX]	Tissue RNA - parathyroid gland [NX]	Tissue RNA - pituitary gland [NX]	Tissue RNA - placenta [NX]	Tissue RNA - pons and medulla [NX]	Tissue RNA - prostate [NX]	Tissue RNA - rectum [NX]	Tissue RNA - retina [NX]	Tissue RNA - salivary gland [NX]	Tissue RNA - seminal vesicle [NX]	Tissue RNA - skeletal muscle [NX]	Tissue RNA - skin 1 [NX]	Tissue RNA - small intestine [NX]	Tissue RNA - smooth muscle [NX]	Tissue RNA - spinal cord [NX]	Tissue RNA - spleen [NX]	Tissue RNA - stomach 1 [NX]	Tissue RNA - testis [NX]	Tissue RNA - thalamus [NX]	Tissue RNA - thymus [NX]	Tissue RNA - thyroid gland [NX]	Tissue RNA - tongue [NX]	Tissue RNA - tonsil [NX]	Tissue RNA - urinary bladder [NX]	Tissue RNA - vagina [NX]	Tissue RNA - B-cells [NX]	Tissue RNA - dendritic cells [NX]	Tissue RNA - granulocytes [NX]	Tissue RNA - monocytes [NX]	Tissue RNA - NK-cells [NX]	Tissue RNA - T-cells [NX]	Tissue RNA - total PBMC [NX]	Cell RNA - A-431 [NX]	Cell RNA - A549 [NX]	Cell RNA - AF22 [NX]	Cell RNA - AN3-CA [NX]	Cell RNA - ASC diff [NX]	Cell RNA - ASC TERT1 [NX]	Cell RNA - BEWO [NX]	Cell RNA - BJ [NX]	Cell RNA - BJ hTERT+ [NX]	Cell RNA - BJ hTERT+ SV40 Large T+ [NX]	Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]	Cell RNA - CACO-2 [NX]	Cell RNA - CAPAN-2 [NX]	Cell RNA - Daudi [NX]	Cell RNA - EFO-21 [NX]	Cell RNA - fHDF/TERT166 [NX]	Cell RNA - GAMG [NX]	Cell RNA - HaCaT [NX]	Cell RNA - HAP1 [NX]	Cell RNA - HBEC3-KT [NX]	Cell RNA - HBF TERT88 [NX]	Cell RNA - HDLM-2 [NX]	Cell RNA - HEK 293 [NX]	Cell RNA - HEL [NX]	Cell RNA - HeLa [NX]	Cell RNA - Hep G2 [NX]	Cell RNA - HHSteC [NX]	Cell RNA - HL-60 [NX]	Cell RNA - HMC-1 [NX]	Cell RNA - HSkMC [NX]	Cell RNA - hTCEpi [NX]	Cell RNA - hTEC/SVTERT24-B [NX]	Cell RNA - hTERT-HME1 [NX]	Cell RNA - hTERT-RPE1 [NX]	Cell RNA - HUVEC TERT2 [NX]	Cell RNA - JURKAT [NX]	Cell RNA - K-562 [NX]	Cell RNA - Karpas-707 [NX]	Cell RNA - LHCN-M2 [NX]	Cell RNA - MCF7 [NX]	Cell RNA - MOLT-4 [NX]	Cell RNA - NB-4 [NX]	Cell RNA - NTERA-2 [NX]	Cell RNA - OE19 [NX]	Cell RNA - PC-3 [NX]	Cell RNA - REH [NX]	Cell RNA - RH-30 [NX]	Cell RNA - RPMI-8226 [NX]	Cell RNA - RPTEC TERT1 [NX]	Cell RNA - RT4 [NX]	Cell RNA - SCLC-21H [NX]	Cell RNA - SH-SY5Y [NX]	Cell RNA - SiHa [NX]	Cell RNA - SK-BR-3 [NX]	Cell RNA - SK-MEL-30 [NX]	Cell RNA - SuSa [NX]	Cell RNA - T-47d [NX]	Cell RNA - THP-1 [NX]	Cell RNA - TIME [NX]	Cell RNA - U-138 MG [NX]	Cell RNA - U-2 OS [NX]	Cell RNA - U-2197 [NX]	Cell RNA - U-251 MG [NX]	Cell RNA - U-266/70 [NX]	Cell RNA - U-266/84 [NX]	Cell RNA - U-698 [NX]	Cell RNA - U-87 MG [NX]	Cell RNA - U-937 [NX]	Cell RNA - WM-115 [NX]	Blood RNA - basophil [NX]	Blood RNA - classical monocyte [NX]	Blood RNA - eosinophil [NX]	Blood RNA - gdT-cell [NX]	Blood RNA - intermediate monocyte [NX]	Blood RNA - MAIT T-cell [NX]	Blood RNA - memory B-cell [NX]	Blood RNA - memory CD4 T-cell [NX]	Blood RNA - memory CD8 T-cell [NX]	Blood RNA - myeloid DC [NX]	Blood RNA - naive B-cell [NX]	Blood RNA - naive CD4 T-cell [NX]	Blood RNA - naive CD8 T-cell [NX]	Blood RNA - neutrophil [NX]	Blood RNA - NK-cell [NX]	Blood RNA - non-classical monocyte [NX]	Blood RNA - plasmacytoid DC [NX]	Blood RNA - T-reg [NX]	Blood RNA - total PBMC [NX]	Brain RNA - amygdala [NX]	Brain RNA - basal ganglia [NX]	Brain RNA - cerebellum [NX]	Brain RNA - cerebral cortex [NX]	Brain RNA - hippocampal formation [NX]	Brain RNA - hypothalamus [NX]	Brain RNA - midbrain [NX]	Brain RNA - olfactory region [NX]	Brain RNA - pons and medulla [NX]	Brain RNA - thalamus [NX]	Single Cell Type RNA - Alveolar cells type 1 [NX]	Single Cell Type RNA - Alveolar cells type 2 [NX]	Single Cell Type RNA - B-cells [NX]	Single Cell Type RNA - Basal glandular cells [NX]	Single Cell Type RNA - Basal keratinocytes [NX]	Single Cell Type RNA - Bipolar cells [NX]	Single Cell Type RNA - Cardiomyocytes [NX]	Single Cell Type RNA - Cholangiocytes [NX]	Single Cell Type RNA - Ciliated cells [NX]	Single Cell Type RNA - Club cells [NX]	Single Cell Type RNA - Collecting duct cells [NX]	Single Cell Type RNA - Cone photoreceptor cells [NX]	Single Cell Type RNA - Cytotrophoblasts [NX]	Single Cell Type RNA - Distal tubular cells [NX]	Single Cell Type RNA - Ductal cells [NX]	Single Cell Type RNA - Early spermatids [NX]	Single Cell Type RNA - Endothelial cells [NX]	Single Cell Type RNA - Enterocytes [NX]	Single Cell Type RNA - Erythroid cells [NX]	Single Cell Type RNA - Exocrine glandular cells [NX]	Single Cell Type RNA - Extravillous trophoblasts [NX]	Single Cell Type RNA - Fibroblasts [NX]	Single Cell Type RNA - Glandular cells [NX]	Single Cell Type RNA - granulocytes [NX]	Single Cell Type RNA - Hepatocytes [NX]	Single Cell Type RNA - Hofbauer cells [NX]	Single Cell Type RNA - Horizontal cells [NX]	Single Cell Type RNA - Intestinal endocrine cells [NX]	Single Cell Type RNA - Ito cells [NX]	Single Cell Type RNA - Kupffer cells [NX]	Single Cell Type RNA - Late spermatids [NX]	Single Cell Type RNA - Leydig cells [NX]	Single Cell Type RNA - Macrophages [NX]	Single Cell Type RNA - Melanocytes [NX]	Single Cell Type RNA - monocytes [NX]	Single Cell Type RNA - Mucus-secreting cells [NX]	Single Cell Type RNA - Muller glia cells [NX]	Single Cell Type RNA - Pancreatic endocrine cells [NX]	Single Cell Type RNA - Paneth cells [NX]	Single Cell Type RNA - Peritubular cells [NX]	Single Cell Type RNA - Proximal tubular cells [NX]	Single Cell Type RNA - Rod photoreceptor cells [NX]	Single Cell Type RNA - Sertoli cells [NX]	Single Cell Type RNA - Smooth muscle cells [NX]	Single Cell Type RNA - Spermatocytes [NX]	Single Cell Type RNA - Spermatogonia [NX]	Single Cell Type RNA - Suprabasal keratinocytes [NX]	Single Cell Type RNA - Syncytiotrophoblasts [NX]	Single Cell Type RNA - T-cells [NX]	Single Cell Type RNA - Undifferentiated cells [NX]	Single Cell Type RNA - Urothelial cells [NX]	RNAsingleCellTypeSpecific
RASD2	MGC:4834, Rhes, TEM2	ENSG00000100302	RASD family member 2	Q96D21	22	35540868-35554001	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 71.0;seminal vesicle: 25.2	Cell type enriched	Detected in some	4	Sertoli cells: 45.3	Low cancer specificity	Detected in many			Region enhanced	Detected in all		basal ganglia: 71.0	Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		GAMG: 4.3;hTERT-RPE1: 13.4;SK-BR-3: 7.6;U-2 OS: 4.4;U-87 MG: 5.5	Region enriched	Detected in many	8	basal ganglia: 527.8	Region enriched	Detected in all	8	basal ganglia: 265.8	HPA005839	Enhanced		Approved	Plasma membrane,Cytosol						Plasma membrane, Cytosol		HPA005839: AB_1079745	unprognostic (1.76e-2)	unprognostic (1.98e-1)	unprognostic (3.33e-2)	unprognostic (7.00e-2)	unprognostic (1.43e-1)	unprognostic (7.07e-3)	unprognostic (9.76e-2)	unprognostic (5.49e-2)	unprognostic (2.06e-1)	unprognostic (1.12e-1)	unprognostic (1.04e-1)	unprognostic (9.00e-3)	prognostic unfavorable (2.22e-5)	unprognostic (3.75e-2)	unprognostic (1.61e-1)	unprognostic (8.42e-3)	unprognostic (6.22e-2)	1.6	7.9	8.6	2.5	71	3.4	1.3	1.8	23.5	1.1	8.3	2.2	3.2	2.5	3.5	16.4	5.2	6.2	2.5	2.8	4.1	5	0.8	0.5	1.5	0.6	3.4	8	0.8	1	0.9	1	0.4	2.1	9.6	4.4	3.5	4	25.2	13.6	0.8	3.4	7.5	2.2	0.4	1.8	0.6	15.3	0	1.4	0.1	1.4	3.8	1.2	0	0	0	0	0	0.3	0	0.2	2.8	0	0.5	0	0	0.1	0.7	0.2	1.1	0.9	0.1	0.5	0	0.2	2.4	4.3	0.1	0.2	0	1	0	0.7	0	0.1	0	1.4	0	0	0.2	3.3	2.2	0.3	13.4	0	0	0	0	0.2	0.2	0	0.2	0.2	0.2	0.3	1.3	0	0.9	0	0	2	0.3	2.2	7.6	0	0.2	0.6	0.2	0.1	1.8	4.4	0.2	0.8	1.9	0.6	0	5.5	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	8.6	71	1.8	23.5	4.1	5	3.4	8	2.1	15.3	0	0	0	0.2	0	0.6	1.7	0	0	0	0	0	0	0	0.2	0	0.5	0.4	0	0.2	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	10.9	0	0	0.2	0.7	0	0.1	45.3	4.1	0	0.1	0.1	0	0	0.2	0.1	Sertoli cells
THBS4		ENSG00000113296	Thrombospondin 4	P35443	5	79991311-80083287	Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins	Cell adhesion, Tissue remodeling, Unfolded protein response	Growth factor, Mitogen	Cancer-related genes	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		adipose tissue: 69.8;heart muscle: 59.0;skeletal muscle: 61.7;smooth muscle: 94.0	Cell type enriched	Detected in many	9	Sertoli cells: 485.0	Low cancer specificity	Detected in all			Low region specificity	Detected in many			Cell type enriched	Detected in single	51	eosinophil: 8.0	Lineage enriched	Detected in single	51	granulocytes: 8.0	Cell line enhanced	Detected in some		AF22: 5.1;SCLC-21H: 4.0;THP-1: 10.9;U-2 OS: 4.7;U-266/70: 4.2	Low region specificity	Detected in some			Not detected	Not detected			CAB004597, HPA042426	Approved		Approved	Vesicles	Secreted to extracellular matrix				420000000	Vesicles		CAB004597: AB_628352, HPA042426: AB_2677992	unprognostic (1.41e-1)	unprognostic (5.33e-2)	unprognostic (4.26e-3)	unprognostic (3.64e-2)	unprognostic (9.94e-2)	unprognostic (8.10e-2)	unprognostic (5.64e-2)	unprognostic (7.12e-2)	unprognostic (1.66e-1)	unprognostic (2.25e-1)	unprognostic (2.06e-1)	unprognostic (2.14e-1)	unprognostic (1.96e-3)	unprognostic (2.74e-2)	unprognostic (3.98e-2)	unprognostic (1.76e-3)	prognostic unfavorable (3.33e-4)	69.8	1	7.6	2.1	8.3	3.7	9.7	0.8	4.6	1.1	21.4	2.6	1.2	1.3	12.2	13.6	6.5	1.4	4.1	59	6.4	6.4	0.8	0.6	1	0.9	8.5	1.9	2.1	23	5.5	7.8	0.6	10.7	3.7	3.7	4.9	19.8	2.6	61.7	1.5	1.4	94	11.5	0.6	4	5.5	2.6	2	9.9	39.3	4.1	3.4	2.7	0.1	0	8	0	0	0.1	0	0.2	0	5.1	0.3	0.4	2.2	0.5	0.1	0.2	1.5	0.5	0.1	0.6	0.2	0.2	0.4	1.3	0.2	0.2	0.6	1.3	0.2	0.7	0.5	0	0.3	2.8	0	0.1	1.6	0.3	0.1	0.3	0.5	0	0.1	0	0.3	0.3	0.7	0.1	0.1	3.9	0	0.1	0	1.6	0	0.4	0.1	4	1.2	0.1	0	0.4	2.3	0	10.9	0	0.1	4.7	0.3	0.3	4.2	0.1	0.7	1.8	3.5	0.9	0	0	8	0	0	0	0	0.1	0	0	0.1	0	0.1	0	0	0	0	0	0	7.6	8.3	0.8	4.6	6.4	6.4	8.5	1.9	10.7	2.6	0	0.6	0	0	0.2	1.2	5	0	0	1.2	3.5	53	0	0	0.1	28	2.2	0	0	0	0	2.7	0.8	0	0	0.1	1.6	8.6	0.6	0	3.2	0.9	0	1.7	0	0	1.9	0	0	41.1	0.6	1.9	485	2.2	16.9	1.4	0.9	0	0	0	0	Sertoli cells
PDGFRB	CD140b, JTK12, PDGFR, PDGFR1	ENSG00000113721	Platelet derived growth factor receptor beta	P09619	5	150113837-150155872	Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins	Chemotaxis	Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase	Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in many			Cell type enriched	Detected in many	5	Sertoli cells: 1267.6	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enhanced	Detected in some		gdT-cell: 2.9;non-classical monocyte: 4.1	Group enriched	Detected in many	8	monocytes: 4.1;T-cells: 2.9	Group enriched	Detected in some	4	ASC diff: 173.0;ASC TERT1: 59.9	Low region specificity	Detected in all			Low region specificity	Detected in all			CAB003842, CAB018144, HPA028499	Enhanced		Supported	Golgi apparatus,Vesicles					35000000	Vesicles	Golgi apparatus	CAB003842: AB_562328, CAB018144: AB_2162497, HPA028499: AB_10602018	unprognostic (4.75e-2)	unprognostic (2.48e-1)	unprognostic (5.21e-2)	unprognostic (3.60e-2)	unprognostic (3.27e-1)	unprognostic (5.61e-2)	unprognostic (1.02e-1)	unprognostic (3.36e-2)	unprognostic (2.12e-2)	unprognostic (2.57e-3)	unprognostic (6.72e-2)	unprognostic (1.25e-1)	prognostic unfavorable (5.87e-8)	unprognostic (3.13e-3)	unprognostic (1.25e-2)	unprognostic (5.47e-2)	prognostic unfavorable (8.11e-4)	61.8	10.4	8.3	11	9.1	0.5	66.1	4.6	10.4	73.1	15.7	6.7	6.9	5.1	44.3	17.3	21.7	26.1	51.7	24.2	8.2	3.9	17	4.6	28.9	21.5	7.9	8.1	46.5	7.5	10.4	7.7	46.4	7.7	24.2	6.3	22.9	11.2	19.3	29.8	20.3	11.2	29.8	5	19.6	9.2	21.5	6.7	1.4	21.4	16	7.3	23.6	35.1	0.4	0.1	0	4.1	0	2.9	0.6	0	0	1	0	173	59.9	0.4	6	25.1	4.2	7.1	0.6	0	0	0.8	17.3	2.4	0	0	0	2	0	0	0	0.4	0.4	24.5	0	0	27	0	5.8	0	13.5	0	0	0	0.6	0.6	0	0	0	1.1	0	0	0.4	0.3	0	0	0	0	3.2	0	0	0	5	0	0	0	6.8	2.2	2.9	0.3	0	0	0	4.2	0	0.1	0	0	0	2.9	0.6	0	0.4	0.1	0.8	0.1	0.1	0	1.3	0	0	4.1	0	0	0.6	8.3	9.1	4.6	10.4	8.2	3.9	7.9	8.1	7.7	6.7	0	0.6	0	0.5	21.3	5	13.4	0	1.4	0	1.8	3.9	0.6	0	0	0.8	16.2	0	0	0	1	68.8	0.6	0	1.5	1.4	0	0	6.7	0	4.7	153.1	2.2	23.6	1	0	74.9	0.1	0	191.6	0	1.1	1267.6	273.4	1.1	1.5	13.4	0.7	1	0.4	0.9	Sertoli cells
WNT6		ENSG00000115596	Wnt family member 6	Q9Y6F9	2	218859821-218874233	Predicted secreted proteins	Wnt signaling pathway	Developmental protein		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 23.4	Cell type enriched	Detected in some	9	Sertoli cells: 90.5	Cancer enhanced	Detected in many		ovarian cancer: 8.7	Group enriched	Detected in many	7	basal ganglia: 23.4;thalamus: 7.4	Cell type enhanced	Detected in some		myeloid DC: 1.1;NK-cell: 1.5	Low lineage specificity	Detected in many			Cell line enriched	Detected in some	7	BEWO: 28.1	Low region specificity	Detected in many			Low region specificity	Detected in many			HPA070759	Approved				Secreted to extracellular matrix							HPA070759: AB_2732164	unprognostic (1.86e-2)	unprognostic (6.03e-2)	unprognostic (5.14e-2)	unprognostic (2.06e-1)	unprognostic (5.32e-2)	unprognostic (7.34e-2)	unprognostic (8.08e-3)	unprognostic (4.73e-2)	unprognostic (1.27e-2)	unprognostic (1.19e-1)	unprognostic (1.21e-2)	unprognostic (2.66e-1)	unprognostic (1.24e-3)	unprognostic (5.26e-2)	unprognostic (4.82e-2)	unprognostic (1.55e-1)	unprognostic (2.07e-1)	2.5	3.5	0.8	1.4	23.4	0.6	15	0.9	2.1	4	5.7	0.2	1.1	1.3	2.3	2	3.1	2.3	2.1	4.8	0.9	0.3	1.6	0.7	0.7	1.3	2.1	0.1	2.9	1.7	0.6	1.7	9.8	1.4	4	0.9	4.3	1.9	2.1	2.4	2.3	2.3	2	2.4	6.4	2.3	3.7	7.4	0	0.7	0.8	1.2	1.5	11.1	0.7	1.1	0	0.6	1.5	0.1	0	0	0	0	0.9	0	0	28.1	0	0	0	0	2.6	0.4	0	3	0	0.1	0.4	0	0	0	0	0.2	0.2	0	0	0	1.5	0	0	0	0	0	0	0	0	0	0.4	0	0.4	0	0.7	0	0	0	0	0	2.8	0.1	0	0	4.1	1.3	0	0	3.2	0.1	3.7	0	0	2.3	0	0	0	0	0	0	2.4	0.1	0	0.6	0	0	0	0	0	0.1	0	1.1	0.7	0	0	0	1.5	0	0.7	0	0	0.8	23.4	0.9	0.9	0.9	0.3	2.1	0.1	1.4	7.4	0	0	0.5	10.5	0.5	0.8	0.4	0	0	0	0	0	4.6	0	0.2	1.6	0	0	0	0	1.5	0.8	3.2	0	0	0.7	1.6	0	3.1	0	3.4	0	0	1.7	0	0	0.8	0	0	0.4	0	1.8	90.5	3.3	2.1	0.3	0.1	0.6	0	0	0.9	Sertoli cells
CNR1	CANN6, CB-R, CB1, CB1A, CB1K5, CNR	ENSG00000118432	Cannabinoid receptor 1	P21554	6	88139864-88166359	Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters		G-protein coupled receptor, Receptor, Transducer	FDA approved drug targets, Obesity	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 30.5	Cell type enriched	Detected in some	14	Sertoli cells: 97.0	Cancer enriched	Detected in many	13	glioma: 12.5	Low region specificity	Detected in all			Group enriched	Detected in some	5	memory B-cell: 2.9;naive B-cell: 2.1	Lineage enriched	Detected in single	6	B-cells: 2.9	Group enriched	Detected in some	7	ASC diff: 40.3;HSkMC: 26.6	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA042256, HPA069945	Enhanced	Supported	Supported	Plasma membrane,Actin filaments						Plasma membrane	Actin filaments	HPA042256: AB_2677917, HPA069945: 	unprognostic (1.28e-1)	unprognostic (7.04e-2)	unprognostic (4.61e-2)	unprognostic (4.08e-3)	unprognostic (1.21e-1)	unprognostic (1.07e-3)	unprognostic (1.37e-1)	unprognostic (2.07e-2)	unprognostic (2.49e-1)	unprognostic (1.16e-2)	unprognostic (2.74e-2)	unprognostic (2.68e-1)	unprognostic (1.70e-1)	unprognostic (5.59e-3)	unprognostic (2.68e-3)	unprognostic (5.88e-2)	unprognostic (7.00e-2)	19.4	6.4	18	5.2	15.8	1.5	14.9	13.8	30.5	3.9	5.5	0.8	0.8	2.3	3.1	4.7	3.7	5.5	3.6	1.4	17.6	7.7	0.9	0.7	6.4	6.5	2.3	14.7	4.1	1.8	1.3	18.3	5.2	4.2	1.5	5.1	0	4.3	4	1.7	2.4	4.2	5.8	3.2	2.3	2.3	2.7	2.8	0	2.6	0	9.9	2.7	3.1	2.9	0	0.4	0	0	0	0.1	0	0	1.8	0	40.3	4.8	0	0	0	0	0	0	0	0.1	0	0	0	0	2.9	0	0	0	0.1	0.9	1.4	0	2.6	0	0	26.6	0	0	0	0	0	0	0.8	0	0	0	0	0	0.6	0	0	0.1	0.2	0	3.3	0	0.8	0	0	0	0	0.1	0	0.6	2.3	0	0	0	0	0	0.7	3.3	0	0	1.3	0	0	0	0	0	0	2.9	0	0	0	2.1	0	0	0.4	0	0	0	0	0.1	18	15.8	13.8	21.4	17.6	7.7	2.3	14.7	4.2	2.8	0	7.2	2.7	0.4	0.6	0.2	0.5	0	0	0	0	0	0	0	0.1	0.2	0.6	0	0	0	0	0.5	0	0	0	0.1	0	0	0	0.3	0	1.4	0	0	0	0	0	0	0	0.4	0	0.1	97	2.3	0	0.1	0.1	0.1	0	0	0.7	Sertoli cells
GNRH2		ENSG00000125787	Gonadotropin releasing hormone 2	O43555	20	3043622-3045747	Predicted secreted proteins		Hormone		Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in many		epididymis: 10.2	Cell type enriched	Detected in single	7	Sertoli cells: 6.5	Cancer enhanced	Detected in some		testis cancer: 1.9	Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in many		U-266/84: 7.5									HPA004338	Uncertain				Secreted to blood							HPA004338: AB_1079012	unprognostic (1.29e-1)	unprognostic (1.88e-1)	unprognostic (1.20e-2)	unprognostic (2.51e-1)	unprognostic (2.26e-2)	unprognostic (1.87e-2)	unprognostic (1.36e-2)	unprognostic (4.04e-3)	unprognostic (7.00e-2)	unprognostic (1.93e-2)	unprognostic (2.47e-4)	unprognostic (2.69e-1)	unprognostic (2.98e-2)	unprognostic (1.72e-1)	unprognostic (3.29e-2)	unprognostic (3.43e-2)	unprognostic (2.21e-2)	0.8	0.9	0.6	1.2	0.9	0.4	0.5	5.1	1.7	1.6	0.5	0.5	0.5	0.3	1.3	10.2	0.5	2.4	2	1.1	0.7	1.2	1.7	3.3	0.5	0.6	1.5	0.5	5.6	0.5	0.5	1.8	0.5	1.2	4.2	0.1	1	1.6	2	0.5	0.1	0.5	0.5	0.5	0.5	2.2	3.9	0.5	0.5	2.8	0.5	0.5	0.5	0.5	0.4	0	0	0	0	0	0	1	1.2	3.2	4	2	0.5	0.6	0.8	0	0.5	0.8	1.9	0.8	1.5	0.1	0.2	1.2	3.3	1.3	1.1	0.9	1.2	3.6	1.3	1.1	2.5	0	0.2	2.2	2.5	2.6	2.5	0	0.4	0.8	2.6	1.5	0.5	1.3	1.1	0.8	2.5	1.4	0	0	0.9	0.4	0.8	0.5	2.8	4.5	2.1	0.2	2.7	1.5	1.5	2.9	1.4	0	1.9	0.9	1.6	1.8	1.1	7.5	1	1.7	1.5	1.1	0	0	0	0	0	0	0.3	0	0	0	0.4	0	0	0	0	0	0	0	0	0.6	0.9	5.1	1.7	0.7	1.2	1.5	0.5	1.2	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.8	0	0	0	0	0.1	0.1	0	0	0	0.1	0	0	0	0	1	0	0	0	0	0	0	0.1	0	0.4	0	0	6.5	0	0	0	0	0	0	0	0	Sertoli cells
HAPLN2	BRAL1	ENSG00000132702	Hyaluronan and proteoglycan link protein 2	Q9GZV7	1	156619294-156625725	Predicted secreted proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	39	brain: 108.1	Cell type enriched	Detected in some	4	Sertoli cells: 32.3	Cancer enriched	Detected in some	10	glioma: 7.6	Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		SH-SY5Y: 1.1;U-266/70: 4.6;U-87 MG: 1.3	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA045765	Enhanced				Secreted in brain							HPA045765: AB_10964781	unprognostic (3.19e-3)	unprognostic (1.06e-1)	unprognostic (1.02e-2)	unprognostic (3.41e-1)	unprognostic (1.88e-1)	unprognostic (2.44e-1)	unprognostic (1.92e-1)	unprognostic (2.04e-3)	unprognostic (1.31e-1)	unprognostic (8.25e-2)	unprognostic (5.54e-3)	unprognostic (2.72e-2)	unprognostic (2.70e-2)	unprognostic (1.08e-1)	unprognostic (2.25e-1)	unprognostic (1.05e-1)	unprognostic (4.17e-3)	1.5	1.5	11	1.3	21.1	1.3	1.3	4.4	45.3	1.3	1.3	43.6	0	2.7	1.6	1.3	1.3	1.4	1.3	1.3	21.2	13.9	1.4	1.3	1.4	1.3	49.3	9.3	1.3	1.3	1.6	0	1.3	43.1	1.9	1.3	0	1.4	1.5	1.9	1.6	1.7	1.3	108.1	1.3	1.3	1.7	31.5	0	1.3	0	1.3	1.3	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0.7	0	0.5	0	0	0	0	0	0	0.3	0.4	0.7	0.3	0	0	0	0.4	0	0	0	0	0	0	0.3	0.7	0.2	0	0	0.2	0.1	0	0	0	0	0.4	0	0	0	0	1.1	0	0	0	0	0.2	0	0	0	0.5	0.2	0	4.6	0.1	0.2	1.3	0	0.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	11	21.1	4.4	15.1	21.2	13.9	49.3	9.3	43.1	31.5	0	0	0	0	0.1	1.3	0.8	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0.1	0	0	0	1.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	32.3	7.6	0.7	1.9	0	0	0	0	0.1	Sertoli cells
RGS5		ENSG00000143248	Regulator of G protein signaling 5	O15539	1	163111121-163321791	Predicted intracellular proteins		Signal transduction inhibitor		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in many			Cell type enriched	Detected in many	8	Sertoli cells: 5031.8	Cancer enhanced	Detected in all		renal cancer: 226.3	Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Group enriched	Detected in some	4	HUVEC TERT2: 92.7;SH-SY5Y: 307.8	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA001821		Supported										HPA001821: AB_1079806	unprognostic (3.75e-1)	unprognostic (3.93e-3)	unprognostic (2.31e-1)	unprognostic (6.91e-2)	unprognostic (2.50e-2)	unprognostic (1.32e-3)	unprognostic (1.65e-2)	unprognostic (7.38e-2)	unprognostic (3.54e-3)	unprognostic (2.19e-1)	unprognostic (1.53e-2)	unprognostic (1.48e-1)	prognostic unfavorable (9.17e-4)	unprognostic (3.81e-3)	unprognostic (7.05e-2)	unprognostic (6.08e-2)	unprognostic (1.41e-1)	38.3	96.6	23.8	16.1	42.1	0.5	18.4	11.9	28.6	62.6	28.5	11.6	20.8	19.5	23.3	19.8	28.1	22.7	43.5	67.8	28.3	22	32.4	10.3	24.9	9.2	37.9	20.8	15.5	9.3	19.5	18.3	6.3	41.7	34.4	13.8	59.3	8.8	59.9	37.1	6.8	48.6	83.1	19.7	5.7	27.3	13.4	20.8	4.1	53.6	35	11.7	77.5	20.7	2.2	0.4	0.5	0.5	0.6	2.3	0.5	0	0	4.5	0.5	0	0.2	0.1	0	0.3	0.1	0.1	0.3	0.1	0	0.6	0	0	0	0	0	0.2	0.2	0	0	0	0	0.1	0	0	0.1	0.1	0.1	0.1	1	92.7	0	0	0	0.3	0	0	0.1	2.7	48.3	0.1	0	0	0.2	0	0	0.3	307.8	0	0	0.1	14.1	0	0	0.3	0.1	0.1	0	0.1	0.1	0	0	0.1	0	0.2	0	0.2	0	0.4	0.4	2.3	2.2	2.1	1	0.4	1.2	2.1	2	0.5	0.6	0.5	0.2	1.1	0.5	23.8	42.1	11.9	28.6	28.3	22	37.9	20.8	41.7	20.8	3	9.3	0	5	15.1	0.7	0	0	8.1	12.5	1.8	3.9	1.1	1.7	0.8	16	24.8	0	0	1	0.7	13.7	10.9	1.1	0	1	0	0	0	0	12.4	6.4	10.2	21.9	1	0.2	2.4	2.4	0	2.5	1.9	4.6	5031.8	595	4.1	1.8	11	1	0.5	0.2	5.7	Sertoli cells
DAAM2	KIAA0381	ENSG00000146122	Dishevelled associated activator of morphogenesis 2	Q86T65	6	39792298-39904877	Predicted intracellular proteins	Wnt signaling pathway			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		brain: 83.3	Cell type enriched	Detected in many	5	Sertoli cells: 148.8	Cancer enhanced	Detected in all		melanoma: 21.5	Low region specificity	Detected in all			Cell type enriched	Detected in single	29	neutrophil: 2.8	Lineage enriched	Detected in single	29	granulocytes: 2.8	Cell line enhanced	Detected in some		HSkMC: 25.8;JURKAT: 13.8;LHCN-M2: 25.3;SK-MEL-30: 31.3;WM-115: 12.2	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA051300, HPA054630	Approved		Supported	Nucleoplasm,Vesicles,Cytosol						Nucleoplasm	Vesicles, Cytosol	HPA051300: AB_2681430, HPA054630: AB_2682549	unprognostic (7.53e-2)	unprognostic (6.02e-3)	unprognostic (4.49e-2)	unprognostic (7.93e-2)	unprognostic (8.24e-2)	unprognostic (4.28e-2)	unprognostic (2.43e-2)	unprognostic (1.05e-3)	unprognostic (1.33e-1)	unprognostic (5.89e-2)	unprognostic (2.17e-1)	unprognostic (5.24e-2)	prognostic unfavorable (2.79e-4)	unprognostic (2.67e-2)	unprognostic (8.54e-2)	unprognostic (7.94e-2)	unprognostic (8.54e-4)	21.5	17.8	34.8	6.7	43	1.7	7.8	4.4	52.2	9.3	6.4	83.3	8	7.6	7.5	8.5	28.3	8.9	5.9	6.1	40.4	25.2	5.9	4	8.4	2.8	42.8	24.8	7.3	5.2	3.5	2.1	9.4	41.3	8.7	7.1	5.1	4.3	17.6	23.8	4.4	8.9	13.7	48.8	15.5	7	8.7	51.9	0	5	2.1	2.2	4.6	4.1	0	0	2.8	0	0	0	0	0	0	2.6	0	5.7	0.1	0.1	4.4	5.9	1	0.5	0.4	0	0	0.2	6.6	2.1	0	0	0	0.4	0	1	0	0	0	4.1	0	0	25.8	0	0.1	0	7.2	0	13.8	0	0	25.3	0	0.6	0	0.7	1.3	0	0	4.6	3.5	0	0	0.9	1	0	0.3	31.3	5.6	0	0	0.2	9.6	2.8	0.1	0.1	0	0	0	0.1	0	12.2	0	0	0	0	0	0	0	0	0	0	0	0	0	2.8	0	0	0	0	0	34.8	43	4.4	28.9	40.4	25.2	42.8	24.8	41.3	51.9	8.9	9.8	0	0.8	1.5	1.7	2.1	0	2.7	6.8	0	0	0.4	0	0.4	3.6	2	0	0	3	0.4	11.3	0.8	0	1	0.2	0	0	3.1	15.2	4.2	21.9	3.1	8.5	0	0	8.2	0.4	0	20.8	0	1.5	148.8	28.3	0.7	1.1	1	0.2	0	0	1	Sertoli cells
FABP4	A-FABP, aP2	ENSG00000170323	Fatty acid binding protein 4	P15090	8	81478419-81483263	Cancer-related genes, Plasma proteins, Predicted intracellular proteins	Transport		Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	9	adipose tissue: 492.7;breast: 545.8	Cell type enriched	Detected in many	4	Sertoli cells: 705.0	Group enriched	Detected in all	7	breast cancer: 42.1;cervical cancer: 141.7;head and neck cancer: 133.8;urothelial cancer: 65.5	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	145	ASC diff: 282.1;RT4: 139.6	Not detected	Not detected			Not detected	Not detected			HPA002188, CAB024961	Enhanced								30000000			CAB024961: , HPA002188: AB_1078822	unprognostic (4.81e-2)	unprognostic (2.30e-3)	unprognostic (1.64e-3)	unprognostic (2.63e-2)	unprognostic (2.58e-1)	unprognostic (8.70e-3)	unprognostic (1.78e-3)	unprognostic (1.67e-1)	unprognostic (2.00e-1)	unprognostic (2.36e-1)	unprognostic (9.32e-2)	unprognostic (1.56e-1)	unprognostic (8.76e-2)	unprognostic (1.13e-3)	unprognostic (4.48e-2)	unprognostic (2.26e-2)	unprognostic (1.39e-1)	492.7	3.5	0.3	16.1	0.3	0.1	545.8	0.2	0.2	0.9	42.2	0	1.8	0.2	0.6	2.9	4.8	1	7.6	15.6	0.3	0.3	1.2	0.4	9.3	4.7	0.3	0	0.7	1.3	2.2	0.3	15.9	0.3	7.7	2.9	0.1	7.6	1.7	13	5.5	4.5	3.3	0.3	0.7	2.2	6.1	0	0.7	7.4	7.3	0.1	15.4	60.2	0	0	0	0	0	0	0	0	0	0	0	282.1	0	0	0	0	0	0	0	0	0	0	0	1.4	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0.2	0	0.6	0	0	0	0.2	0	0	0	0	0	0.1	0	0	0	0	139.6	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0.3	0.2	0.2	0.3	0.3	0.3	0	0.3	0	32.8	75	1.5	0.4	12.8	0.2	16.2	0	40.2	48.9	0	0	0.3	0	0.1	0.9	172.1	0	0	4.6	0.6	7.6	0.4	25.6	0	120.8	0	0	12.9	57	0.6	1.4	13.8	15.1	1	0	0.7	0.1	0	1.1	0	1.7	705	59.7	0	0.1	12.2	0.6	0	0	61.1	Sertoli cells
SCN4B	LQT10	ENSG00000177098	Sodium voltage-gated channel beta subunit 4	Q8IWT1	11	118133377-118152888	Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters	Ion transport, Sodium transport, Transport	Ion channel, Sodium channel, Voltage-gated channel	Atrial fibrillation, Disease mutation, FDA approved drug targets, Long QT syndrome	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 36.4;skeletal muscle: 25.6	Cell type enriched	Detected in some	4	Sertoli cells: 45.3	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		AN3-CA: 3.9;HBEC3-KT: 3.0;NTERA-2: 4.4;SH-SY5Y: 1.7;U-2 OS: 4.0	Region enriched	Detected in many	11	basal ganglia: 731.2	Region enhanced	Detected in many		basal ganglia: 122.8	HPA017293	Approved											HPA017293: AB_2184174	unprognostic (1.98e-1)	unprognostic (1.13e-1)	unprognostic (1.13e-1)	unprognostic (2.43e-1)	unprognostic (1.45e-1)	unprognostic (1.07e-1)	unprognostic (9.82e-3)	unprognostic (9.17e-3)	unprognostic (1.20e-2)	unprognostic (1.23e-2)	unprognostic (1.03e-2)	unprognostic (3.27e-2)	unprognostic (1.07e-1)	unprognostic (2.07e-2)	unprognostic (2.18e-3)	unprognostic (1.53e-1)	unprognostic (5.31e-4)	20.5	5.4	1.9	1.2	36.4	0.1	6.1	11.7	21.7	2.4	2.6	2	0.5	2.4	3.7	1.8	5.4	5.5	3.2	11	3.1	2.9	1.4	0.6	8.7	2	5.3	2.1	0.7	5	6.4	2.4	1.9	28.7	2.1	2.2	4.3	2.8	2.6	25.6	3.8	4.6	7	5.5	0.5	3	0.8	8.7	1.5	10.4	9.5	1.1	3.4	1.5	0	0	0	0	0	0	0	0.2	0	0	3.9	0	0	0.2	1	0	0	0	0	0	0	0.1	0	0.6	0.6	0.3	3	0	0	0.8	0	0	0	0	0	1.1	0.5	0	0	0.4	0	0	0	0	0	0	0	0	0	4.4	0	0	0	0	0.1	0	0	0.1	1.7	0.4	0	0	1.1	0	0	0	0	4	0	0	0	0	0.1	0	0.1	1.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.9	36.4	11.7	21.7	3.1	2.9	5.3	2.1	28.7	8.7	0	0	0	0.3	1.1	1.1	2.8	0	6.7	1.2	0	0	0	0	0	1.3	0.7	0	0	0	0	1.6	0.1	0	0	0.1	0	0	0	0.3	3.3	2	0.8	0	0	0	0.3	0	0	1.4	0	0.3	45.3	10.8	0	0.6	1	0	0	0	0.1	Sertoli cells
C9orf47	bA791O21.3, C9orf108, FLJ37523	ENSG00000186354	Chromosome 9 open reading frame 47	Q6ZRZ4	9	88990863-88996140	Predicted secreted proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Low tissue specificity	Detected in many			Cell type enriched	Detected in some	4	Sertoli cells: 12.9	Not detected	Not detected							Cell type enriched	Detected in single	5	classical monocyte: 2.2	Lineage enriched	Detected in single	6	monocytes: 2.2	Cell line enhanced	Detected in some		AF22: 6.6;ASC diff: 3.2;HeLa: 5.6;JURKAT: 3.5									CAB009902	Approved				Secreted - unknown location							CAB009902: AB_2184764	unprognostic (6.51e-3)	unprognostic (2.50e-1)	unprognostic (2.94e-4)	unprognostic (2.24e-3)	unprognostic (1.75e-1)	unprognostic (1.46e-1)	unprognostic (2.47e-2)	unprognostic (9.39e-2)	unprognostic (2.10e-2)	unprognostic (2.98e-1)	unprognostic (7.39e-2)	unprognostic (1.98e-1)	unprognostic (4.19e-6)	unprognostic (5.61e-2)	unprognostic (3.72e-2)	unprognostic (6.91e-2)	unprognostic (1.77e-2)	1.7	5.3	0.6	1	0.7	0.8	2.3	0	0.7	1.8	1			0.3	1.1	0.6	2.1	2.1	0.9	1.8	0.8	0.5	3.9	0.8	1	1.7	0.4		0.4	1.7	0	3.3	1.2		1.9	0.2		0.3	0.8	0	0	0.8	1.4	0.5	1.7	1	0			0.7		0.5	0.9	1.9	0	0.2	0.3	2.2	0	0	0.4	0	0.4	6.6	0.2	3.2	1.9	0.1	1.1	0.3	0.4	0.5	0	0	0	0	0.5	0.5	0	0	0.4	0.5	0	0.1	0	5.6	0	0	0.4	0	0.2	0.1	0.7	0	0.2	0.7	3.5	0.3	0	0	0.5	1.6	1.4	0.4	0	0.3	0.7	0	0	0	0.6	0.2	0.5	0.3	0.1	0	0.7	0.1	1.8	1.8	0.6	1.4	1.1	0	0	0	0	0.7	0.5	0.1	0	2.2	0	0	0.4	0	0	0	0	0.2	0	0	0	0.3	0	0.1	0	0	0.4											0	0	0	2	2.6	0	1.2	0	0	0	0	0	1	0	0	0	0.6	0	0	0.2	0.1	1.2	1	0	0	0.2	3.2	0	0.6	0	0	0.3	0	1.7	0	0	2.6	0	0	0.4	0	0	12.9	1.4	0	0.2	0.3	0.2	0	0	0.6	Sertoli cells
PRSS48	ESSPL	ENSG00000189099	Serine protease 48	Q7RTY5	4	151277171-151291453	Enzymes, Predicted membrane proteins, Predicted secreted proteins		Hydrolase, Protease, Serine protease		Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Group enriched	Detected in some	5	brain: 1.0;skin 1: 1.9;testis: 4.1	Cell type enriched	Detected in some	6	Sertoli cells: 6.5	Not detected	Not detected							Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HHSteC: 1.4;LHCN-M2: 1.4;PC-3: 1.5;RT4: 1.0	Not detected	Not detected			Low region specificity	Detected in all			HPA053801	Uncertain				Secreted in male reproductive system							HPA053801: AB_2682267			unprognostic (9.68e-2)		unprognostic (1.35e-2)			unprognostic (2.15e-1)		unprognostic (2.18e-2)				unprognostic (3.76e-2)	unprognostic (4.10e-2)			0	0	0.5	0	1	0	0	0	0.9	0	0.1			0	0	0	0	0.1	0	0	0.7	0.1	0	0	0.1	0	0.2		0	0	0	0	0.1		0	0		0	0.3	0	1.9	0	0	0.5	0	0	4.1			0		0	0	0	0	0.4	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	1.4	0	0.6	0	0	0	0	0	0	0	0	0	1.4	0	0	0	0.6	0	1.5	0	0	0	0	1	0	0	0	0.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0											0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0.3	6.5	0	1.1	1.1	0	0	0	0	0	Sertoli cells
ZFP92	ZNF897	ENSG00000189420	ZFP92 zinc finger protein	A6NM28	X	153418322-153426481	Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	DNA-binding		Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		ovary: 6.7	Cell type enriched	Detected in some	6	Sertoli cells: 19.4	Cancer enhanced	Detected in some		ovarian cancer: 3.2					Cell type enhanced	Detected in single		intermediate monocyte: 1.8	Low lineage specificity	Detected in single			Cell line enhanced	Detected in some		HDLM-2: 6.1;HMC-1: 5.9;THP-1: 3.9;U-937: 10.1	Region enhanced	Detected in many		hypothalamus: 10.3	Low region specificity	Detected in all			HPA003030	Uncertain											HPA003030: AB_2666758	unprognostic (6.94e-2)	unprognostic (2.54e-2)	unprognostic (7.85e-2)	unprognostic (2.57e-4)	unprognostic (1.01e-2)	unprognostic (3.84e-2)	unprognostic (1.21e-1)	unprognostic (1.54e-1)	unprognostic (1.65e-2)	unprognostic (1.62e-2)	unprognostic (6.51e-3)	unprognostic (6.71e-2)	unprognostic (1.84e-1)	unprognostic (8.49e-4)	unprognostic (1.81e-1)	unprognostic (2.71e-2)	unprognostic (6.66e-3)	2	2.8	1.1	0.4	1.5	4	0.8	3.6	2.5	1.1	0.5			0.1	1.8	4.3	0	5.4	0.4	0.7	0.9	1.9	0.8	0.2	2.3	0.3	0.9		6.7	0.8	1.3	1.8	0.8		0.5	0		0	2.5	0	0	0.6	1.5	0.2	0.6	0.4	0.7			0.4		0.4	0	0	0.4	0	0.1	1.8	0	0.9	0.3	0	0.9	0	0	0	0	0	0.8	1.5	1.4	1.3	0.7	0.1	0	0.8	0.9	0.4	0.7	0.6	0.7	1.1	6.1	0	2.3	0	0	2.5	0.7	5.9	0.4	0.9	0	0.1	0	2.4	1.5	1.8	0	0	0	1.5	0.5	0.3	0.8	0	0	0	0.4	0	0	0.6	1.5	0	0	1.6	0	0.1	3.9	0	0	3	0	0	1.4	0	1.6	0	10.1	0.6	0	0.7	0	0.9	1.8	0.2	0.4	0.1	0	0	0	0.1	0.1	0.1	0	0.3	0	0	0.3											0	0	0	0	0	0.2	0.8	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0.3	0	0	0	0.8	0	0	0.6	0.8	0	2.3	0.5	0	0	0	0.2	0.3	0	3.2	0.2	0.2	19.4	0.8	0.1	0.6	0	0	0	0	0	Sertoli cells
GPR20		ENSG00000204882	G protein-coupled receptor 20	Q99678	8	141356500-141367267	G-protein coupled receptors, Predicted membrane proteins		G-protein coupled receptor, Receptor, Transducer		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Low tissue specificity	Detected in many			Cell type enriched	Detected in some	4	Sertoli cells: 71.1	Low cancer specificity	Detected in some			Low region specificity	Detected in many			Group enriched	Detected in some	12	intermediate monocyte: 3.7;non-classical monocyte: 5.4	Lineage enriched	Detected in single	14	monocytes: 5.4	Cell line enriched	Detected in some	4	EFO-21: 7.0	Not detected	Not detected			Region enhanced	Detected in single		midbrain: 1.3	HPA071337			Supported	Plasma membrane,Cytosol						Plasma membrane	Cytosol	HPA071337: 	unprognostic (4.47e-2)	unprognostic (2.64e-3)	unprognostic (5.18e-2)	unprognostic (2.00e-2)	unprognostic (7.47e-2)	unprognostic (2.28e-1)	unprognostic (4.43e-2)	unprognostic (5.01e-2)	unprognostic (3.54e-1)	unprognostic (2.13e-2)	unprognostic (1.57e-1)	unprognostic (1.13e-1)	unprognostic (1.07e-2)	unprognostic (7.41e-2)	unprognostic (5.50e-2)	unprognostic (6.23e-2)	unprognostic (4.07e-1)	2.8	0.5	0.7	2.7	1.4	0.1	2.5	0.2	2	10.6	9.1	1	4.3	2.2	6.7	1.9	3.4	3.9	6.1	2.1	0.8	0.4	1.1	0.4	3.5	0.3	1.4	0.9	3.7	0.5	0.5	0.5	3.2	2.1	2.2	1	1.1	0.5	3	2.1	1	10.5	4.5	0.5	0.8	4.3	1.6	0.7	0	1.4	1.5	0.5	1.7	3.4	0	0.3	0.3	5.4	0	0	0.1	0	0.8	0	0	0	0.1	0	0.3	0	0	0	0.5	0.1	0	7	0	0.1	0.1	0	0	0	0	0.3	0	1.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.2	0	0	0.5	0.2	0.5	0	0	0.5	0	0	0.3	0	0	0	0	1.1	0	0.1	0	0	1.6	0	0	0	0.1	0	0	0.8	0	0	0	0	0	3.7	0	0	0	0	0.3	0	0	0	0.3	0	5.4	0	0	0.1	0.7	1.4	0.2	2	0.8	0.4	1.4	0.9	2.1	0.7	0	0	0	0.1	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0.1	0	0	0.1	0	0	0	0	0.9	0	0	1.7	0	0	0	0	0	0.4	0	0	71.1	16.5	0	0	0.1	0	0	0	0	Sertoli cells
MEF2B	RSRFR2	ENSG00000213999	Myocyte enhancer factor 2B	Q02080	19	19145568-19170289	Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	Activator, DNA-binding		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	22	lymphoid tissue: 81.2	Cell type enriched	Detected in single	16	Sertoli cells: 6.5	Not detected	Not detected			Low region specificity	Detected in many			Cell type enhanced	Detected in single		neutrophil: 1.1	Low lineage specificity	Detected in single			Group enriched	Detected in some	12	Daudi: 50.9;U-266/70: 51.2;U-698: 67.3	Not detected	Not detected			Low region specificity	Detected in all			HPA004734	Supported		Approved	Nucleoplasm,Cell Junctions,Cytosol						Nucleoplasm, Cytosol	Cell Junctions	HPA004734: AB_10963939	unprognostic (7.31e-3)	unprognostic (4.06e-2)	unprognostic (9.44e-5)	unprognostic (5.07e-2)	unprognostic (2.01e-1)	unprognostic (7.19e-3)	unprognostic (1.64e-1)	unprognostic (1.78e-1)	unprognostic (2.76e-1)	unprognostic (1.98e-2)	unprognostic (8.66e-3)	unprognostic (1.92e-2)	unprognostic (1.56e-11)	unprognostic (2.40e-1)	unprognostic (1.92e-1)	unprognostic (3.68e-1)	unprognostic (8.98e-3)	2	1	0.8	81.2	1.2	1.4	1.9	0.6	1.4	2.7	3	0.9	0.6	1.5	2.2	1.1	1.5	2.3	2.2	1.9	1	0.6	1.8	2.9	2	32.3	1.1	0.9	3.7	0.8	0.8	2.1	0.8	1	3.7	1	1.8	3.5	1.1	1.4	2.3	3.1	1.1	1.2	6.7	1.7	1.7	0.8	1.6	3	3.5	58.7	1.9	2.9	0.1	0.2	1.1	0.9	0	0.2	0	0.2	0.1	0.1	0.2	0.2	0.1	0.1	0	0	0.1	0	0	0.3	50.9	0.1	0.2	0.1	0.4	0	0	0	0.1	0.3	0.1	0.1	0.1	0.2	0.2	0.4	0.1	0.2	0.1	0.1	0.1	0	0.4	0.1	0.5	0	0.2	0.3	0.3	0	0	0.9	0.4	0	1	0	0	0	0.1	0.1	0	0.1	0	0	0.5	0.1	0	0.4	0.5	0.1	51.2	4.7	67.3	0.1	0.3	0	0	0.9	0	0.2	0.1	0.2	0.1	0.1	0.1	0.2	0	0.1	0.2	1.1	0	0	0	0	0	0.8	1.2	0.6	1.4	1	0.6	1.1	0.9	1	0.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	6.5	0	0	0	0	0	0	0	0	Sertoli cells
EBF2	COE2, FLJ11500	ENSG00000221818	Early B cell factor 2	Q9HAK2	8	25841730-26045397	Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	Activator, Developmental protein, DNA-binding		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		adipose tissue: 25.8	Cell type enriched	Detected in some	4	Sertoli cells: 38.8	Low cancer specificity	Detected in many			Region enhanced	Detected in single		pons and medulla: 2.8	Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		ASC diff: 12.5;ASC TERT1: 25.5;HSkMC: 25.9;hTEC/SVTERT24-B: 14.4;U-138 MG: 9.3;U-2197: 12.2;U-87 MG: 10.4	Group enriched	Detected in many	4	basal ganglia: 5.9;cerebellum: 3.4;hypothalamus: 2.4;midbrain: 5.3;pons and medulla: 2.9	Low region specificity	Detected in some			HPA003954, HPA055101			Approved	Nucleoplasm,Nuclear bodies						Nucleoplasm	Nuclear bodies	HPA003954: , HPA055101: 	unprognostic (3.70e-1)	unprognostic (3.88e-3)	unprognostic (2.69e-2)	unprognostic (2.47e-3)	unprognostic (1.03e-1)	unprognostic (6.10e-2)	unprognostic (5.92e-2)	unprognostic (6.75e-2)	unprognostic (1.11e-2)	unprognostic (6.13e-3)	unprognostic (1.58e-1)	unprognostic (1.30e-1)	prognostic unfavorable (2.51e-6)	unprognostic (7.41e-4)	unprognostic (2.28e-1)	unprognostic (3.80e-2)	unprognostic (1.82e-2)	25.8	1.1	0.2	3.2	0.9	0.1	14.5	0.2	0.2	3	4.2	0	2.9	0.2	3	14.1	5.2	5.1	3.8	16.4	0.2	0.5	0.9	0.2	1.3	4.4	0.9	0	3.9	4	3.1	0.6	0.8	2.8	3.7	0.7	0.1	1.7	0.8	11.1	1.8	1	5.4	10.1	0.2	1.2	4.2	0	0.4	7.4	11.6	0.5	6.2	5.4	0	0	0	0	0	0	0	0	0	0.4	0	12.5	25.5	0.2	0.1	0	0	0	0	0	0	0	0	0.8	0	0	0	0.1	0	0.8	0	0	0	0	0	0	25.9	0	14.4	0	0	0	1.2	0	0	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	9.3	0.1	12.2	0	0	0	0	10.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0.9	0.2	0.2	0.2	0.5	0.9	0	2.8	0	0	0.3	0	0.1	0.1	0	4.5	0	0	1.2	0	0	0	0	0	5.2	1.9	0	0	0	0	0.7	0	0	0	0.1	0	0	0	0	1.9	5.5	0	0	0	0	0	0.1	0	0.4	0	0.3	38.8	9.5	0.2	0.2	0.3	0	0	0	0	Sertoli cells
OR4M2		ENSG00000274102	Olfactory receptor family 4 subfamily M member 2	Q8NGB6	15	22070241-22083221	G-protein coupled receptors, Predicted membrane proteins	Olfaction, Sensory transduction	G-protein coupled receptor, Receptor, Transducer		Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in single		testis: 1.1	Cell type enriched	Detected in single	9	Sertoli cells: 6.5	Not detected	Not detected							Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	10	U-2 OS: 1.0									HPA058889	Uncertain											HPA058889: AB_2683845																		0	0		0		0.2	0.1		0.9	0	0			0	0	0	0	0	0	0			0	0	0	0			0	0	0		0		0	0		0	0	0	0	0	0		0	0	1.1			0		0	0		0	0.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.9	0	0	0	0	0	0	0.3	0	0											0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	6.5	0	0	0	0	0	0	0	0	Sertoli cells
ADRA2B	ADRA2L1, ADRA2RL1, ADRARL1	ENSG00000274286	Adrenoceptor alpha 2B	P18089	2	96112875-96116245	Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins		G-protein coupled receptor, Receptor, Transducer	Epilepsy, FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Low tissue specificity	Detected in many			Cell type enriched	Detected in some	4	Sertoli cells: 32.3	Low cancer specificity	Detected in many							Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		BEWO: 5.1;EFO-21: 3.3;HAP1: 1.8;NTERA-2: 1.8;SuSa: 3.1	Low region specificity	Detected in some			Low region specificity	Detected in many			HPA066029, HPA074948	Approved		Supported	Vesicles,Cytosol						Vesicles	Cytosol	HPA066029: AB_2685599, HPA074948: 	unprognostic (6.16e-2)	unprognostic (1.31e-2)	unprognostic (1.76e-2)	unprognostic (4.93e-4)	unprognostic (1.84e-2)	unprognostic (5.24e-2)	unprognostic (6.80e-5)	unprognostic (4.85e-2)	unprognostic (1.69e-1)	unprognostic (3.16e-2)	unprognostic (8.34e-2)	unprognostic (2.54e-1)	unprognostic (2.21e-1)	unprognostic (4.43e-2)	unprognostic (3.39e-1)	unprognostic (1.36e-1)	unprognostic (6.55e-2)	4.9	2.2	0.3	0.4	2.2	1.2	8.1	0.1	0.7	4.5	4	1.9	0.2	0.5	1.3	7.5	4.3	0.8	3.2	6.1	0.5		2.9	7.5	0.3	0.2	4.4	0	5	2.3	1	0	1.3	3.3	3.3	0.4	0.9	1.8	2.9	8	0.3	1.2	2.1	0.6	4.8	0.7	2.6	1.9	0	2.1	1.8	0	3.8	4.9	0	0	0	0	0	0	0	0	0	1	0	0	0	5.1	0	0	0	0	0.1	0.2	0	3.3	0	0.3	0.2	1.8	0	0	0	0.8	0	0.2	0	0	0	0	0	0	0.1	0	0	0	1.1	0	0.2	0	0.7	0	0.1	1.8	0.1	0.3	0	0	0.4	0	0.3	1.4	0	0	1.2	0	3.1	0.3	0.1	0	0	0.4	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0.2	1	0	2	0	1.4	1.2	1.8	0	0.4	0	0.2	0	0.7	0	0	0.5	0.1	0.4	0.9	0	0	0.3	0	2.4	3.1	0.3	0	1.7	0.9	1.7	0	0.1	0	0.1	0	0.4	0	0	32.3	8	0	0.2	1.3	0.3	0	0	0.3	Sertoli cells
